Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models

被引：0

作者：

Zad, Zahra ^{[1
,2
]}

Bonecker, Simone ^{[3
]}

Wang, Taiyao ^{[1
,2
]}

Zalcberg, Ilana ^{[3
]}

Stelzer, Gustavo T. ^{[4
]}

Sabioni, Bruna ^{[5
]}

Gutiyama, Luciana Mayumi ^{[3
]}

Fleck, Julia L. ^{[6
]}

Paschalidis, Ioannis Ch. ^{[1
,2
,7
,8
]}

机构：

[1] Boston Univ, Dept Elect & Comp Engn, Div Syst Engn, Dept Biomed Engn,Fac Comp & Data Sci, Boston, MA 02215 USA

[2] Boston Univ, Hariri Inst Comp & Computat Sci & Engn, Boston, MA 02215 USA

[3] Brazilian Natl Canc Inst INCA, Rio De Janeiro, Brazil

[4] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil

[5] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Dept Hematol, Rio De Janeiro, RJ, Brazil

[6] Univ Clermont Auvergne, Ctr CIS, CNRS, Mines St Etienne,UMR LIMOS 6158, St Etienne, France

[7] Boston Univ, Dept Elect & Comp Engn, Dept Biomed Engn, Div Syst Engn, 8 St Marys St, Boston, MA 02215 USA

[8] Boston Univ, Fac Comp & Data Sci, 8 St Marys St, Boston, MA 02215 USA

来源：

LEUKEMIA RESEARCH | 2024年 / 141卷

基金：

美国国家科学基金会; 美国国家卫生研究院;

关键词：

Chronic Myeloid Leukemia (CML); Imatinib (IM); Deep Molecular Response (DMR); Treatment-free remission (TFR); Supervised Machine Learning; IMATINIB; SURVIVAL; CML;

D O I：

10.1016/j.leukres.2024.107502

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：5

共 50 条

[21] Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
Yeung, David T.
Mauro, Michael J.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 240 - 243
[22] Prediction of automotive response using supervised machine learning in antilock braking systems and comparison with different models for improved vehicle safety
Gunjate, Shital Suresh
Khot, Sanjay A.
ENGINEERING RESEARCH EXPRESS, 2024, 6 (04):
[23] Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study
Shah, Neil P.
Garcia-Gutierrez, Valentin
Jimenez-Velasco, Antonio
Larson, Sarah
Saussele, Susanne
Rea, Delphine
Mahon, Francois-Xavier
Levy, Moshe Yair
Gomez-Casares, Maria Teresa
Pane, Fabrizio
Nicolini, Franck-Emmanuel
Mauro, Michael J.
Sy, Oumar
Martin-Regueira, Patricia
Lipton, Jeffrey H.
LEUKEMIA & LYMPHOMA, 2020, 61 (03) : 650 - 659
[24] A Robust Model for Churn Prediction using Supervised Machine Learning
Bhatnagar, Anurag
Srivastava, Sumit
PROCEEDINGS OF THE 2019 IEEE 9TH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTING (IACC 2019), 2019, : 45 - 49
[25] Improved prediction of clinical outcome in chronic myeloid leukemia
Cojbasic, Irena
Macukanovic-Golubovic, Lana
Mihailovic, Dragan
Vucic, Miodrag
Lukic, Stevo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (02) : 173 - 183
[26] Response Dynamics in Chronic-Phase Chronic Myeloid Leukemia
Mauro, Michael J.
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03) : 217 - 222
[27] Breast cancer prediction using supervised machine learning techniques
Dadheech, Pankaj
Kalmani, Vijay
Dogiwal, Sanwta Ram
Sharma, Vijay Kumar
Kumar, Ankit
Pandey, Saroj Kumar
JOURNAL OF INFORMATION & OPTIMIZATION SCIENCES, 2023, 44 (03) : 383 - 392
[28] Efficient Water Quality Prediction Using Supervised Machine Learning
Ahmed, Umair
Mumtaz, Rafia
Anwar, Hirra
Shah, Asad A.
Irfan, Rabia
Garcia-Nieto, Jose
WATER, 2019, 11 (11)
[29] New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia
Badar, Talha
Luthra, Rajyalakshmi
Kantarjian, Hagop
Jabbour, Elias
Borthakur, Gautam
Garcia-Manero, Guillermo
Huang, Xuelin
Singh, Rajesh
Alvarez, Brittany
Austermiller, Bradley
Morrison, Tom B.
Patel, Keyur P.
Cortes, Jorge
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (01) : 33 - 39
[30] Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors
Cayssials, Emilie
Tartarin, Florence
Guilhot, Joelle
Sorel, Nathalie
Chomel, Jean Claude
Leleu, Xavier
Guilhot, Francois
LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 766 - 769

← 1 2 3 4 5 →